user avatar
Nina Shah
@ninashah33
Joined July 2013
227
Following
6,215
Followers
Posts
  • user avatar
    Nina Shah
    @ninashah33
    Aug 17, 2019
    After a whirlwind myeloma round table, I think I have to face the music and proclaim myself as Myeloma Millennial aka #myelennial See inclusion criteria below (must meet 3). @IreneGhobrial @Rfonsi1 @akeithstewart @SLentzsch @Leif_Bergsagel @EagleMyeloma Anything to add?? #mmsm
  • user avatar
    Nina Shah
    @ninashah33
    Nov 14, 2021
    Sometimes it’s ok to meet outside of an oncology conference…@rachnatshroff
  • user avatar
    Nina Shah
    @ninashah33
    Mar 1, 2022
    So excited for another option for our patients ! CAR-T PAR-TY!! J&J, Legend cell therapy approved by FDA for multiple myeloma | BioPharma Dive ⁦@SandyWong02111⁩ ⁦@TomBmt133 #mmsm
    J&J, Legend cell therapy approved by FDA for multiple myeloma
    From biopharmadive.com
  • user avatar
    Nina Shah
    @ninashah33
    Nov 7, 2020
    I’m an Indian-American woman who grew up in Delaware ... so you know what’s up !!!!
  • user avatar
    Nina Shah
    @ninashah33
    Nov 30, 2020
    Y'all: too much #myelomaresearch goodness to boil it down to Top 10. So here is my #ASH20 Top 10 for bispecifics/ADC's/CAR T. In short - the bispecifics are this year's homecoming queen... More to come... #mmsm
  • user avatar
    Nina Shah
    @ninashah33
    Aug 26, 2022
    Congratulations to @mvmateos (my #styeloma queen) for winning the Bart Barlogie award and @NoopurRajeMD for winning the Ken Anderson award. Inspiring and amazing #woMMen #mmsm #IMS2022
  • user avatar
    Nina Shah
    @ninashah33
    Mar 27, 2021
    Huge news!! Bristol Myers Squibb - U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma
    news.bms.com
    U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma...
    Abecma is a first-in-class BCMA-directed personalized immune cell therapy delivered as a one-time infusion for triple-class exposed patients with multiple myeloma1 In the pivotal KarMMa trial, the...
  • user avatar
    Nina Shah
    @ninashah33
    Mar 26, 2022
    Watch out #myeloma… we are back! #mmsm #woMMen @IreneGhobrial
  • user avatar
    Nina Shah
    @ninashah33
    Jun 4, 2022
    We are BACK-SCO ! ⁦@rachnatshroff⁩
  • user avatar
    Nina Shah
    @ninashah33
    Dec 10, 2021
    You know I must love being a myeloma doc to make it here at 645 am EST = 345 PST. 😆#mmsm @theMMRF @elimanasanch @AkrishnanUsa
  • user avatar
    Nina Shah
    @ninashah33
    Feb 6, 2022
    Could not be happier for my big bro and #frientor @jmikhaelmd and @EmilyVanLaar #DMC @szusmani @Ccostello7 @rabonour1 @ZainabShd @Rfonsi1 #jemforever
  • user avatar
    Nina Shah
    @ninashah33
    Sep 17, 2019
    The woMMen of myeloma: watch out cancer, we are coming for you !!! @IreneGhobrial @SurbhiSidanaMD @SandyWong02111 #mmsm #IMW2019
  • user avatar
    Nina Shah
    @ninashah33
    May 2, 2020
    Social distancing cannot keep our @UCSF #myeloma team apart! @SandyWong02111 @TomBmt133 @myelomawolf #mmsm
  • user avatar
    Nina Shah
    @ninashah33
    Aug 24, 2021
    In true heme fashion my awesome UCSF faMYELy threw me a “Day (-1)” surprise birthday party! Sparkling water & birthday pies 🥳 This is why it’s a blessing to love the people you work with! Thank you @SandyWong02111 @TomBmt133 @myelomawolf @AlfredChung11 @shagunaroramd #45andalive